Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12371923rdf:typepubmed:Citationlld:pubmed
pubmed-article:12371923lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:12371923lifeskim:mentionsumls-concept:C0007806lld:lifeskim
pubmed-article:12371923lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:12371923lifeskim:mentionsumls-concept:C0948008lld:lifeskim
pubmed-article:12371923lifeskim:mentionsumls-concept:C0205178lld:lifeskim
pubmed-article:12371923pubmed:issue5lld:pubmed
pubmed-article:12371923pubmed:dateCreated2002-10-9lld:pubmed
pubmed-article:12371923pubmed:abstractTextAs platelet endothelial cell adhesion molecule-1 (PECAM-1) is one of key mediators of transendothelial migration of leucocytes during inflammation, and inflammatory reaction is observed in cerebral ischaemia, we decided to determine the levels of soluble PECAM-1 (sPECAM-1) in serum and cerebrospinal fluid (CSF) of patients with acute stroke.lld:pubmed
pubmed-article:12371923pubmed:languageenglld:pubmed
pubmed-article:12371923pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12371923pubmed:citationSubsetIMlld:pubmed
pubmed-article:12371923pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12371923pubmed:statusMEDLINElld:pubmed
pubmed-article:12371923pubmed:monthNovlld:pubmed
pubmed-article:12371923pubmed:issn0001-6314lld:pubmed
pubmed-article:12371923pubmed:authorpubmed-author:ZarembaJJlld:pubmed
pubmed-article:12371923pubmed:authorpubmed-author:LosyJJlld:pubmed
pubmed-article:12371923pubmed:issnTypePrintlld:pubmed
pubmed-article:12371923pubmed:volume106lld:pubmed
pubmed-article:12371923pubmed:ownerNLMlld:pubmed
pubmed-article:12371923pubmed:authorsCompleteYlld:pubmed
pubmed-article:12371923pubmed:pagination292-8lld:pubmed
pubmed-article:12371923pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:12371923pubmed:meshHeadingpubmed-meshheading:12371923...lld:pubmed
pubmed-article:12371923pubmed:meshHeadingpubmed-meshheading:12371923...lld:pubmed
pubmed-article:12371923pubmed:meshHeadingpubmed-meshheading:12371923...lld:pubmed
pubmed-article:12371923pubmed:meshHeadingpubmed-meshheading:12371923...lld:pubmed
pubmed-article:12371923pubmed:meshHeadingpubmed-meshheading:12371923...lld:pubmed
pubmed-article:12371923pubmed:meshHeadingpubmed-meshheading:12371923...lld:pubmed
pubmed-article:12371923pubmed:meshHeadingpubmed-meshheading:12371923...lld:pubmed
pubmed-article:12371923pubmed:meshHeadingpubmed-meshheading:12371923...lld:pubmed
pubmed-article:12371923pubmed:meshHeadingpubmed-meshheading:12371923...lld:pubmed
pubmed-article:12371923pubmed:meshHeadingpubmed-meshheading:12371923...lld:pubmed
pubmed-article:12371923pubmed:meshHeadingpubmed-meshheading:12371923...lld:pubmed
pubmed-article:12371923pubmed:meshHeadingpubmed-meshheading:12371923...lld:pubmed
pubmed-article:12371923pubmed:year2002lld:pubmed
pubmed-article:12371923pubmed:articleTitlesPECAM-1 in serum and CSF of acute ischaemic stroke patients.lld:pubmed
pubmed-article:12371923pubmed:affiliationDepartment of Clinical Neuroimmunology, University School of Medicine, Poznan, Poland. jlosy@mail.usoms.poznan.pllld:pubmed
pubmed-article:12371923pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12371923lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12371923lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12371923lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12371923lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12371923lld:pubmed